Brazil suspends import of Lupin's antibiotic ingredients
Brazilian drug regulator ANVISA has suspended import of active ingredients produced by pharma major Lupin used to make antibiotics, citing "unsatisfactory inputs" and deviation from good manufacturing practices (GMP).
Jul 07, 2015, 20:42 PM IST